We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+2.45%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$668M
AUM Growth
+$149M
Cap. Flow
+$135M
Cap. Flow %
20.21%
Top 10 Hldgs %
21.93%
Holding
273
New
69
Increased
70
Reduced
77
Closed
47

Top Sells

Rank Stock Value
1
THC icon
Tenet Healthcare
THC
+$11.7M
2
CSCO icon
Cisco
CSCO
+$10.2M
3
F icon
Ford
F
+$7.83M
4
BA icon
Boeing
BA
+$7.76M
5
ANF icon
Abercrombie & Fitch
ANF
+$7.26M

Sector Composition

Rank Sector Weight
1 Financials 16.92%
2 Technology 15.75%
3 Consumer Discretionary 12.08%
4 Industrials 11.78%
5 Healthcare 10.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMT icon
201
Lockheed Martin
LMT
$136B
$241K 0.04%
1,500
DE icon
202
Deere & Co
DE
$168B
$235K 0.04%
2,600
CYTK icon
203
Cytokinetics
CYTK
$10.4B
$230K 0.03%
48,141
+13,167
+38% +$80.4K
HBOS
204
DELISTED
HERITAGE FINANCIAL GROUP
HBOS
$224K 0.03%
11,290
-475
-4% -$9.02K
XEL icon
205
Xcel Energy
XEL
$48.8B
$219K 0.03%
6,800
SAMG icon
206
Silvercrest Asset Management
SAMG
$79.9M
$214K 0.03%
+12,429
New +$217K
CARB
207
DELISTED
Carbonite Inc
CARB
$211K 0.03%
17,642
-600
-3% -$6.2K
AIG icon
208
American International
AIG
$41.3B
$209K 0.03%
+3,830
New +$203K
STML
209
DELISTED
Stemline Therapeutics, Inc.
STML
$207K 0.03%
14,095
-250
-2% -$3.83K
ARGS
210
DELISTED
Argos Therapeutics, Inc.
ARGS
$207K 0.03%
1,291
-45
-3% -$7.44K
FRP
211
DELISTED
Fairpoint Communications, Inc.
FRP
$200K 0.03%
14,284
-450
-3% -$6.29K
CERS icon
212
Cerus
CERS
$474M
$189K 0.03%
45,450
-1,300
-3% -$5.57K
QLTY
213
DELISTED
QUALITY DISTR INC FLA
QLTY
$178K 0.03%
11,978
-250
-2% -$3.45K
HCKT icon
214
Hackett Group
HCKT
$287M
$170K 0.03%
28,535
-900
-3% -$5.42K
FOLD
215
DELISTED
Amicus Therapeutics
FOLD
$161K 0.02%
48,064
+23,625
+97% +$55.5K
SPNS
216
DELISTED
Sapiens International
SPNS
$159K 0.02%
19,822
-200
-1% -$1.57K
NEON icon
217
Neonode
NEON
$16.2M
$146K 0.02%
4,657
+684
+17% +$29.7K
CRIS icon
218
Curis
CRIS
$7.83M
$143K 0.02%
38
-2
-5% -$8.15K
IL
219
DELISTED
IntraLinks Holdings Inc.
IL
$128K 0.02%
14,452
FCSC
220
DELISTED
Fibrocell Science Inc.
FCSC
$119K 0.02%
1,984
-34
-2% -$1.9K
NRX
221
DELISTED
NEPHROGENEX INC COM
NRX
$116K 0.02%
19,125
-575
-3% -$3.67K
ARQL
222
DELISTED
Arqule Inc
ARQL
$107K 0.02%
68,712
-2,025
-3% -$3.17K
RVLT
223
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
$77K 0.01%
3,327
-103
-3% -$2.66K
ACHV icon
224
Achieve Life Sciences
ACHV
$683M
$71K 0.01%
9
NAUH
225
DELISTED
National American University Holdings, Inc.
NAUH
$60K 0.01%
19,444
-43,112
-69% -$147K

Similar funds

Stoneridge Investment Partners's Q2 2014 Portfolio in Review

As of Q2 2014, Stoneridge Investment Partners held 273 positions worth $668M, up 29% from $518M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Stoneridge Investment Partners deployed $135M of net new capital in Q2 2014, opening 69 new positions and adding to 70 existing holdings. Its largest new stake was Aetna Inc: 121,534 shares worth $9.85M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Philip Morris, an estimated $6.5M trimmed.

  • Stoneridge Investment Partners's largest Q2 2014 buy was Aetna Inc: 121,534 shares worth $9.85M.
  • Stoneridge Investment Partners added most to Viatris in Q2 2014, an estimated $8.58M increase.
  • Stoneridge Investment Partners's biggest Q2 2014 reduction was Philip Morris, cutting an estimated $6.5M.
  • Stoneridge Investment Partners fully exited Tenet Healthcare in Q2 2014, selling an estimated $11.7M.
  • Stoneridge Investment Partners's ten largest holdings make up 22% of its $668M portfolio in Q2 2014.
  • Stoneridge Investment Partners opened 69 new positions and closed 47 in Q2 2014.
  • Stoneridge Investment Partners's portfolio value rose 29% quarter-over-quarter to $668M.

Based on Stoneridge Investment Partners's 13F filing for Q2 2014, filed 16 Jul 2014.